Find the right fit for you - faster
Get tailored insights about working at Esperion Therapeutics in one quick step.
Esperion Therapeutics Snapshot
Our Vision: Innovation Today, for Healthier Lives Tomorrow
Our Mission: At Esperion, we are working tirelessly to deliver innovative medicines that help patients reach their goals today, tomorrow, and into the future.
Our Mission: At Esperion, we are working tirelessly to deliver innovative medicines that help patients reach their goals today, tomorrow, and into the future.
Esperion was founded in 2008. Since then, our teams have worked diligently to discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work.
Today and every day, we strive to reimagine how those in need manage their heart health. In pursuit of this effort, we’re committed to setting – and reaching – goals that support our patients, our healthcare providers and society at large.
We have set a goal to give prescribers innovative options to reduce LDL-cholesterol, with the goal of reducing overall cardiovascular risk.
We have set a goal to empower patients to manage their LDL-cholesterol and educate them on the importance of cardiovascular risk reduction.
We have set a goal to provide at-risk populations with access to available treatments.
Esperion, Reaching Goals
Today and every day, we strive to reimagine how those in need manage their heart health. In pursuit of this effort, we’re committed to setting – and reaching – goals that support our patients, our healthcare providers and society at large.
We have set a goal to give prescribers innovative options to reduce LDL-cholesterol, with the goal of reducing overall cardiovascular risk.
We have set a goal to empower patients to manage their LDL-cholesterol and educate them on the importance of cardiovascular risk reduction.
We have set a goal to provide at-risk populations with access to available treatments.
Esperion, Reaching Goals
